ROTTINGHAUS SCOTT T. (Chief Medical Officer) reported 1 transaction at ENANTA PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 8/10/2026ACC: 0002064832-26-000266
Officer· Chief Medical Officer
Since Feb 2026
-1.47K
Net shares
Net seller
$19.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.47K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.47K
Price / share
$13.34
Trade value
$19.57K
% of position
5.8%
8/8/2026
25.25K→23.79K
Total
Net shares
−1.47K
Net value
-$19.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/8/2026 | F · Tax Withholding | −1.47K | $13.34 | $19.57K | 5.8% | 25.25K | 23.79K |
| Total | −1.47K | -$19.57K | ||||||
Derivative Transactions0
No derivative transactions reported